Chris Freeman - Chief Commercial Officer at Guardant Health, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Commercial Officer
Stock Symbol
GH on Nasdaq
Industry
Services-Medical Laboratories
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Chris Freeman since 7/7/2023

Holdings reported by Chris Freeman for Guardant Health, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 25,769 $728 K $28.26 Jul 1, 2024 Direct
Restricted Stock Units 17,356 $490 K $28.26 Jul 1, 2024 Direct Common Stock
STOCK OPTION (RIGHT TO BUY) 29,861 Dec 13, 2023 Direct COMMON STOCK

Transactions reported by Chris Freeman for Guardant Health, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership